Promomed's revenues for 9 months increased by 34%

Promomed's revenue for 9 months of 2024 amounted to ₽10.7 billion, up 34% year-on-year. In the endocrinology segment, revenue increased by 49% to ₽3.1 billion. Oncology sales grew by 58% to ₽2.5 billion.